LY2157299 is a TGF-beta type I receptor kinase inhibitor. LY2157299 has been used to inhance chemotherapy action against triple negative breast cancer (TNBC). Molecular Formula: C22H19N5O Solubility: DMSO (Slightly), Methanol (Slightly) Molecular Weight: 369.42 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
369.42
Form:
Supplied as a white to off-white solid.
CAS Number:
[700874-72-2]
* VAT and and shipping costs not included. Errors and price changes excepted